Figure 2

High AFAP1-AS1 expression predicts poor prognosis in PDAC patients with surgical resection. a) and b) Patients were equally divided into two groups based on AFAP1-AS1 mRNA levels. The log-rank test (2-sided) was used to compare differences between groups. The Kaplan–Meier curves show analyses of overall survival and progression-free survival. (c) ROC curve analysis was conducted to investigate the value of AFAP1-AS1 in predicting tumor progression (recurrence and/or metastasis) within 6 months or 1 year after surgical resection.